0001209191-22-049721.txt : 20220913 0001209191-22-049721.hdr.sgml : 20220913 20220913165956 ACCESSION NUMBER: 0001209191-22-049721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220909 FILED AS OF DATE: 20220913 DATE AS OF CHANGE: 20220913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schor Chen CENTRAL INDEX KEY: 0001340875 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 221241340 MAIL ADDRESS: STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC. STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adicet Bio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: resTORbio, Inc. DATE OF NAME CHANGE: 20171024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-09 0 0001720580 Adicet Bio, Inc. ACET 0001340875 Schor Chen C/O ADICET BIO, INC. 200 BERKELEY STREET, 19TH FLOOR BOSTON MA 02116 1 1 0 0 President & CEO Common Stock 2022-09-09 4 S 0 8094 16.5062 D 66747 I See Footnote Common Stock 2022-09-12 4 S 0 66747 16.7694 D 0 I See Footnote Common Stock 2022-09-12 4 S 0 200 18.00 D 143060 I See Footnote Common Stock 2022-09-13 4 S 0 3371 18.0105 D 139689 I See Footnote Common Stock 122712 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.50 to $16.56, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission ("SEC") staff upon request. Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.50 to $16.96, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $18.00 to $18.05, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. /s/ Nick Harvey, Attorney-in-Fact 2022-09-13